Abstract
OBJECTIVES: To prospectively investigate patient-reported outcomes and clinical performance of implant supported overdentures in edentulous Sjögren's disease (SjD) patients compared to subjects without SjD. METHODS: 51 implants were placed in 12 patients with SjD and 50 implants in 12 non-SjD patients to support overdentures. Clinical performance, marginal bone-level changes, patient satisfaction and oral health related quality of life (OHRQoL) were assessed at 1 (T1), 6 (T6), 12 (T12) and 18 (T18) months after placement of the overdenture. Patient satisfaction, ability to chew and OHRQoL were assessed with validated questionnaires. Marginal bone-level changes were measured on standardised dental radiographs. Clinical parameters included implant and overdenture survival, plaque, bleeding and gingival indices, and probing depth. RESULTS: OHRQoL in patients with SjD improved significantly after placement of implant supported overdentures at all measuring moments compared to baseline (p<0.05). Nevertheless, ability to chew tough and hard food was significantly better for non-SjD patients at all timepoints after placement of an implant supported overdenture (p<0.05). Implant survival at T18 was 100% in the patients with SjD and 98% in the non-SS group. Mean marginal bone loss at T18 did not differ between patients with SjD and non-SS patients, 1.12±0.74 mm and 1.43±1.66 mm, respectively (p=0.58). Clinical performance was good with no differences between the groups for all outcome measures (p>0.05). CONCLUSIONS: Implant-supported overdentures have a positive effect on OHRQoL and dental implants can be successfully applied in edentulous patients with SjD with nearly similar outcomes as in non-SjD subjects.
Original language | English |
---|---|
Pages (from-to) | 2418-2427 |
Number of pages | 10 |
Journal | Clinical and Experimental Rheumatology |
Volume | 41 |
Issue number | 12 |
Early online date | 23 Dec 2023 |
DOIs | |
Publication status | Published - Dec 2023 |
Funding
Funding: this study was funded by unconditional research grants from Foundation NutsOhra (FNO; grant/award number: 1303-042), Amsterdam, the Netherlands and Biohorizons Inc (grant/award number: CI15002), Birmingham, AL, USA. Competing interests: none declared.
Funders | Funder number |
---|---|
Netherlands and Biohorizons Inc | CI15002 |
Fonds NutsOhra | 1303-042 |